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Introduction 
Over the past 20 years, China has undergone an 
increased acceptance of Western ideologies. This is 
particularly true regarding an increased popularity of 
Western medicine in China. Westernization of China 
has led to a transition from traditional Chinese 
medicine to Western medicine [1]. The impact of 
Western medicine in China on the field of 
dermatology is not well characterized. A connection 
might exist between the Westernization of medicine 
in China and an increased impact on the field of 
dermatology from China. 
In this study, we sought to assess the contributions 
China has provided to the field of dermatology. We 
analyzed the trend in total publications to six major 
dermatologic journals from China and compared this 
to two other nearby Asian countries: Japan and 
Korea. We suspect that China’s increased acceptance 
of Western medicine is associated with a positive 
trend regarding publications in major dermatologic 
journals. 
 
Methods 
The PubMed advanced search builder was utilized to 
search for publications coming from China, Japan, 
and Korea in six major dermatologic journals for the 
past 20 years. We searched for publications that 
reported their country as “China,” “Japan,” and 
“Korea” under affiliation in the details and/or author 
information section. The journals selected to be 
analyzed were the following: The Journal of the  
Abstract 
Background: Over the past 20 years, China has 
experienced an increased popularity of Western 
medicine. The impact of Western medicine in China 
on the field of dermatology is not well characterized. 
Objective: To assess the impact China has had on the 
field of dermatology by analyzing the total 
publications to six dermatological journals, 
compared to two other Asian countries: Japan and 
Korea. 
Methods: PubMed was utilized to search for 
publications from China, Japan, and Korea within the 
past 20 years. Descriptive statistics were used to 
determine the average percentage change in 
publications during this 20-year period, and the 
average annual increase in total number of 
publications from each country. Comparisons were 
made using one-way ANOVA and two-group t-tests. 
Results: From 1998 to 2019, there was a 24% average 
annual increase in publications from China (M=24.4, 
SD=24.5), compared to a 6% increase from Japan 
(M=5.6, SD=25.4, P=0.02) and 8% increase from Korea 
(M=7.8, SD=23.4, P=0.03). 
Conclusion: For the past 20 years, there has been a 
strong positive trend regarding the total number of 
publications from China. This finding might be 
related in part to an increased acceptance of Western 
medicine, which follows a similar trend during the 
time period we analyzed.  
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American Academy of Dermatology, The British Journal 
of Dermatology, JAMA Dermatology, The Journal of 
Investigative Dermatology, The Journal of 
Dermatological Science, and The Journal of 
Dermatology. These journals were selected based on 
their respective impact factors and total cites, 
according to the SCImago Journal and Country Rank 
[2]. 
The results by year were downloaded directly from 
PubMed. We analyzed the total number of 
publications from 1998 to 2019. Descriptive statistics 
were used to determine the average percentage 
change in publications during this 20-year period, as 
well as the average annual increase in total number 
of publications from each of the three countries. 
One-way ANOVA and two-group t-tests were used to 
make comparisons between the total number of 
publications from China, Japan, and Korea. P values 
<0.05 were considered significant. 
 
Results 
There was a significant difference between the total 
number of publications from China, Japan, and Korea 
by year since 1998 at the P<0.05 level: [F(2,60)=3.72, 
P=0.03]. From 1998 to 2019, there was a total of 1,235 
publications from China, 6,274 from Japan, and 1,329 
from Korea in the six journals we analyzed (Figure 1). 
During this 20-year period, there was a 24% average 
annual increase in publications from China (M=24.4, 
SD=24.5), compared to a 6% increase from Japan 
(M=5.6, SD=25.4, P=0.02) and 8% increase from 
Korea (M=7.8, SD=23.4, P=0.03). 
 
Figure 1. Comparison of the total number of publications from 
China, Japan, and Korea in the six major dermatologic journals we 
assessed: The Journal of the American Academy of Dermatology, 
The British Journal of Dermatology, JAMA Dermatology, The 
Journal of Investigative Dermatology, The Journal of 
Dermatological Science, and The Journal of Dermatology. From 
1998 to 2019, there was a total of 1,235 publications from China, 
6,274 from Japan, and 1,329 from Korea. 
 
Figure 2. Comparison of the total number of publications from China in the six major dermatologic journals we assessed. A positive trend 
exists regarding the increased number of publications from China in each of the six journals: The Journal of the American Academy of 
Dermatology, The British Journal of Dermatology, JAMA Dermatology, The Journal of Investigative Dermatology, The Journal of 
Dermatological Science, and The Journal of Dermatology. From 1998 to 2019, there was a 24% average annual increase in publications 
from China (Mean=24.4, SD=24.5), compared to a 6% increase from Japan (Mean=5.6, SD=25.4, P=0.02) and 8% increase from Korea 
(Mean=7.8, SD=23.4, P=0.03). 
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In 1998, there was a total of three publications from 
China in the following journals: The Journal of the 
American Academy of Dermatology, The British Journal 
of Dermatology, JAMA Dermatology, The Journal of 
Investigative Dermatology, The Journal of 
Dermatological Science, and The Journal of 
Dermatology. In 2019, the total number of 
publications in these journals was 205, the highest it 
has ever been. Going from three publications in 1998 
to 205 publications in 2019 is a 6,733% total increase 
in annual publications. To put this into perspective, 
there were more publications from China in these 
dermatologic journals in just the year 2019 (205) 
than there were in 11 years from 1998 to 2009 (195), 
(Figure 2). In 2019, there were 33 publications in The 
Journal of the American Academy of Dermatology, 55 
publications in The British Journal of Dermatology, 15 
publications in JAMA Dermatology, 43 publications in 
The Journal of Investigative Dermatology, 14 
publications in The Journal of Dermatological Science, 
and 45 publications in The Journal of Dermatology 
(Figure 2). 
 
Discussion 
From 1998 to 2019, a positive trend exists regarding 
the total number of publications coming from China 
in the six major dermatologic journals we analyzed 
(Figures 1, 2). During this time, there has been a 
consistent annual increase in dermatologic 
publications. For the past 20 years, China’s 
contributions to many major dermatologic journals 
has increased exponentially. The rise in dermatologic 
publications in China is likely associated with 
increased funding from the National Nature and 
Science Foundation of China (NSFC), which is an 
organization that is affiliated with China’s state 
council and supports basic and applied research [3]. 
Such funding has helped lead to a massive 
expansion in the field of dermatology in China, 
especially within the past 10 years. According to the 
Science Citation Index, Chinese dermatologists have 
published more than 1,000 papers over the past 5 
years [3]. 
The increase in dermatologic publications in China 
might be explained by the increased popularity of 
Western medicine in China. The country was once 
dominated by traditional Chinese medicine. 
However, the influence of Western medicine over the 
years has led to it becoming the most popular form 
of medicine in China [4]. In 1993, based on the quota 
established by China’s government, an average 
county-level traditional Chinese hospital had about 
15 physicians trained in traditional Chinese medicine 
(TCM), compared to only 10 physicians trained in 
Western medicine [1]. Only 15 years later in 2008, the 
number of TCM physicians working in a typical 
county-level traditional Chinese hospital barely 
changed (about 16-17), whereas the number of 
Western medicine physicians increased from 10 to 30 
during this time [1]. Additionally, in a survey of 97 
TCM hospitals and 103 general hospitals between 
1999 and 2004, the percentage of service revenue 
from Western medicine increased from 44.3% to 
47.4%, compared to a decrease in TCM service 
revenue from 26.4% to 18.8% [5]. China’s national 
statistics also showed a similar trend, with an 
increased percentage of revenue from Western 
medicine for TCM hospitals from 59.3% in 1999 to 
62.2% in 2003 and 66.1% in 2008; however, the 
percentage of revenue from TCM declined from 18% 
in 1999 to 15.4% in 2003 and 13.7% in 2008 [5]. This 
timeline of Westernization of medicine in China 
aligns very well with the period in which a significant 
increase in dermatologic publications occurred. 
Not only has the quantity of publications from China 
increased, but the quality of publications has 
become stronger as well. Recently, some major 
contributions from China include the following: 
establishing the relationship between HLA-B*13:01 
and dapsone hypersensitivity syndrome [6] and 
identifying several novel susceptibility loci for 
leprosy [7], psoriasis [8, 9], vitiligo [10], atopic 
dermatitis [11], and systemic lupus erythrematosus 
[12]. Chinese dermatologists also helped discover 
how psoriasis progression is associated with IL23 
stimulating dermal gamma-delta T cells to produce 
IL17 [13]. Additionally, they have helped characterize 
whole-genome DNA methylation patterns in 
involved and uninvolved skin lesions from patients 
with psoriasis via methylated DNA 
immunoprecipitation sequencing [14]. They were  
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also the first to identify the mutations in SCN9A, 
which leads to a defective voltage-gated sodium 
channel alpha subunit and ultimately causes primary 
erythromelalgia [15]. These are just some of the 
many major contributions China has made to the 
field of dermatology within the past 15 years. 
This study has limitations. The PubMed advanced 
search builder relied on publications to report their 
country as “China,” “Japan,” and “Korea” under 
affiliation in the details and/or author information 
section in order to be counted as a publication from 
one of the three countries. Thus, the actual total 
publication count from these countries might be 
higher than our results show. However, we believe 
the results are valid in the analysis of China’s 
increased contributions to the field of dermatology 
and the exploration of its association with China’s 
increased popularity of Western medicine. 
 
Conclusion 
The Westernization of medicine in China and 
increased numbers of publications to major 
dermatologic journals from China follows a similar 
positive trend during the same time period we 
analyzed (1998 to 2019). Thus, an association might 
exist between China’s acceptance of Western 
medicine and an increased contribution to the field 
of dermatology for the past 20 years. 
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